Plasma rich in growth factors effective for high ankle sprain recovery in elite athletes .
This report has been verified
by one or more authors of the
original publication.
Plasma rich in growth factors (PRGF) as a treatment for high ankle sprain in elite athletes: a randomized control trial
Knee Surg Sports Traumatol Arthrosc. 2015 Nov;23(11):3383-9215 elite athletes (16 ankles) with grade 3 high ankle sprains, with complete anteroinferior tibiofibular ligament (AITFL) tears, were included in this study. The purpose of the study was to determine how ultrasound-guided platelet-rich in Growth Factor (PRGF) injections effect recovery, return to play, and dynamic stability in this injury. The results displayed that athletes who received PRGF injections had a significantly shorter return to play times and a lower number of patients returning to play with residual pain compared to the control group. Sonographic evaluations displayed no significant differences in the syndesmotic opening between groups up to 6 weeks post-injury. Further trials using larger sample size and a more generalizable patient population are warranted based on the results of this study.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
